Nantes University Hospital (France) is currently enrolling pregnant women with preeclampsia in a phase 2/3 (safety and efficacy) clinical trial to evaluate the safety and efficacy of citrulline in prolonging pregnancy. Citrulline is a natural amino acid in the body and provides a source of nitric oxide to the body. Nitric oxide dilates blood vessels including blood vessels of the placenta, and therefore may help in preeclampsia and IUGR. More information can be found at: https://clinicaltrials.gov/ct2/show/NCT02801695?recrs=a&cond=Preeclampsia&rank=32
